Anzeige
Mehr »
Login
Mittwoch, 28.09.2022 Börsentäglich über 12.000 News von 675 internationalen Medien
Wo es gerade richtig läuft!? – Wo kann man jetzt Geld verdienen?
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von PMLiVE

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
18.08.bluebird bio's beta-thalassaemia gene therapy receives FDA approval
18.08.AstraZeneca and Merck's Lynparza combination therapy receives FDA priority review in first-line prostate cancer
18.08.GSK's application for momelotinib in myelofibrosis with anaemia accepted by FDA
18.08.Bristol Myers Squibb successfully completes acquisition of Turning Point Therapeutics
18.08.Hanover Health appoints James Mole as a director
17.08.Are we the masters or servants of omnichannel engagement?
17.08.JCVI publishes advice on COVID-19 vaccines ahead of autumn booster campaign
17.08.AstraZeneca and Daiichi Sankyo's Enhertu shows significant improvement for breast cancer patients
17.08.Gilead Sciences announce positive results for Trodelvy in breast cancer patients
17.08.UK government to launch national mission to tackle dementia
17.08.WHO publishes first position paper on optimising brain health
16.08.NHS bowel cancer checks reach record-high following death of Dame Deborah James
16.08.The impact of COVID-19 on the fight against AMR
16.08.WHO releases interim statement on COVID-19 vaccination for children and adolescents
16.08.Novartis reports death of two patients treated with Zolgensma
15.08.Environment: where does the pharmaceutical industry stand?
15.08.NHS England outlines measures to boost capacity ahead of substantial winter pressures
15.08.New research shows drug candidate may effectively treat antibiotic-resistant bacteria
15.08.Sanofi and NIHR enrol first patient in immunisation study for RSV in infants
15.08.Moderna's Omicron booster receives MHRA approval
15.08.Lack of evidence for AstraZeneca's COVID-19 vaccine says UK Department of Health
12.08.That 'don't' impress me much
12.08.Bristol Myers Squibb and GentiBio in $1.9bn deal to develop IBD therapies
12.08.Novartis' Pluvicto receives MHRA marketing authorisation to treat advanced prostate cancer
12.08.AstraZeneca and Daiichi Sankyo receive FDA approval for lung cancer drug